Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma in asia: redefining the role of allogeneic haematopoietic stem cell transplantation.
- DOI
- 10.1007/s00277-026-07126-6
- Published
- 2026 Jun 19
- Container
- Annals of hematology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00277-026-07126-6,
title = {Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma in asia: redefining the role of allogeneic haematopoietic stem cell transplantation.},
author = {Ng LCK and Tan JY and Ong SY and Nagarajan C and Poon MLM and Ho AYL and Lim FWI and Chen Y},
year = {2026},
journal = {Annals of hematology},
doi = {10.1007/s00277-026-07126-6},
url = {https://doi.org/10.1007/s00277-026-07126-6}
}RIS
TY - JOUR TI - Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma in asia: redefining the role of allogeneic haematopoietic stem cell transplantation. AU - Ng LCK AU - Tan JY AU - Ong SY AU - Nagarajan C AU - Poon MLM AU - Ho AYL AU - Lim FWI AU - Chen Y PY - 2026 JO - Annals of hematology DO - 10.1007/s00277-026-07126-6 UR - https://doi.org/10.1007/s00277-026-07126-6 ER -
APA
LCK, N., JY, T., SY, O., C, N., MLM, P., AYL, H., FWI, L., & Y, C. (2026). Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma in asia: redefining the role of allogeneic haematopoietic stem cell transplantation.. Annals of hematology. https://doi.org/10.1007/s00277-026-07126-6
Source records
- pubmed · retrieved 2026-09-26T22:38:44.299Z